Pharmacological Studies in Hospitalized COVID-19 Patients in Belgium: We Could Do Better
Belgium has actively participated in clinical research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since the beginning of the pandemic to help identify effective and safe treatments for COVID-19. The objective of this review is to provide a picture of the clinical studies carried out in hospitalized patients with COVID-19 in Belgium. We collected data on all randomized, interventional trials in patients with COVID-19 that were registered on two recognized clinical trial registers, started enrollment before 31 December 2021, and included at least one patient in a Belgian cen... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2022 |
Reihe/Periodikum: | Viruses, Vol 14, Iss 1427, p 1427 (2022) |
Verlag/Hrsg.: |
MDPI AG
|
Schlagwörter: | Belgium / adaptive platform trials / severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) / Microbiology / QR1-502 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26613774 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.3390/v14071427 |